-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lnt64EyWJa9dChKKAp401my6kh8l32XGTMbpNKOtliOb5OZB4KxXRFlXZdUvB/hW LRvN69g2c0zVZJAGgHR9mg== 0001235645-05-000004.txt : 20050419 0001235645-05-000004.hdr.sgml : 20050419 20050419161732 ACCESSION NUMBER: 0001235645-05-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050415 FILED AS OF DATE: 20050419 DATE AS OF CHANGE: 20050419 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 CHIPETA WAY STE 240 CITY: SALT LAKE CITY STATE: UT ZIP: 84108-1256 BUSINESS PHONE: 8015834939 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER ALAN L CENTRAL INDEX KEY: 0001235645 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 05759485 MAIL ADDRESS: STREET 1: 420 CHIPETA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2005-04-15 0000890465 NPS PHARMACEUTICALS INC NPSP 0001235645 MUELLER ALAN L 383 COLOROW DRIVE SALT LAKE CITY UT 84108 0 1 0 0 VP, Drug Discovery Incentive Stock Option 12.97 2005-04-15 2005-04-15 4 A 0 2527 12.97 A 2006-04-15 2015-04-15 Common Stock 2527 2527 D Non-Qualified Stock Option 12.97 2005-04-15 2005-04-15 4 A 0 6348 12.97 A 2006-04-15 2015-04-15 Common Stock 6348 6348 D Incentive Stock Option 12.97 2005-04-15 2005-04-15 4 A 0 438 12.97 A 2006-04-15 2015-04-15 Common Stock 438 438 I Spouse Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter. Kevin J. Ontiveros 2005-04-19 -----END PRIVACY-ENHANCED MESSAGE-----